title: Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Elena M
authors.initials: EM
authors.lastname: Massarotti
authors.affiliation: Yale School of Medicine, New Haven, Connecticut.
authors.forename: Heather G
authors.initials: HG
authors.lastname: Allore
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Karen
authors.initials: K
authors.lastname: Costenbader
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D016898:Interferon-alpha; D008180:Lupus Erythematosus, Systemic
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D016898:Interferon-alpha; C582345:anifrolumab